NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球藥物濫用治療市場:2021∼2028年

Global Substance Abuse Treatment Market - 2021-2028

出版商 DataM Intelligence 商品編碼 1023075
出版日期 內容資訊 英文 180 Pages
商品交期: 約2個工作天內
價格
全球藥物濫用治療市場:2021∼2028年 Global Substance Abuse Treatment Market - 2021-2028
出版日期: 2021年08月12日內容資訊: 英文 180 Pages
簡介

將處方藥和OTC藥,違法藥物和酒精等,在本來的使用目的外過剩使用,稱為藥物濫用。藥物濫用,有引起社會、身體、精神、工作上的問題的可能性。

本報告提供全球藥物濫用治療市場相關調查,市場概要,以及各治療類型,各流通管道,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 藥物濫用治療市場調查手法和範圍

  • 調查手法
  • 調查的目的和調查範圍

第2章 藥物濫用治療市場-市場定義和概要

第3章 藥物濫用治療市場-摘要整理

  • 各治療類型的市場明細
  • 各流通管道的市場明細
  • 各地區的市場明細

第4章 藥物濫用治療市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 藥物濫用治療市場-產業分析

  • 波特的五力分析
  • 流行病學分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 償付分析
  • 未滿足需求

第6章 藥物濫用治療市場-COVID-19分析

  • 市場上的Covid-19分析
    • COVID-19前的市場方案
    • COVID-19目前市場方案
    • COVID-19後或未來方案
  • Covid-19的價格動態
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府舉措
  • 製造商策略性舉措
  • 結論

第7章 藥物濫用治療市場-各治療類型

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%),各治療類型
    • 市場魅力指數
  • 香煙/尼古丁中毒治療
    • 簡介
    • 市場規模分析,百萬美元,2019∼2028年,及與前一年同期比較成長分析(%),2020∼2028年
  • 藥物依賴治療
  • 其他

第8章 藥物濫用治療市場-各流通管道

  • 簡介
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場魅力指數
  • 院內藥局
    • 簡介
    • 市場規模分析,百萬美元,2019∼2028年,及與前一年同期比較成長分析(%),2020∼2028年
  • 零售藥局

第9章 藥物濫用治療市場-各地區

  • 簡介
    • 市場規模分析,百萬美元,2019∼2028年,及與前一年同期比較成長分析(%),2020∼2028年,各地區
    • 市場魅力指數
  • 北美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各治療類型
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 歐洲
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各治療類型
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 南美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各治療類型
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 亞太地區
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各治療類型
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道
    • 市場規模分析,及與前一年同期比較成長分析(%),各國
  • 中東和非洲
    • 簡介
    • 主要地區具體動態
    • 市場規模分析,及與前一年同期比較成長分析(%),各治療類型
    • 市場規模分析,及與前一年同期比較成長分析(%),各流通管道

第10章 藥物濫用治療市場-競爭情形

  • 主要的發展與策略
  • 企業佔有率分析
  • 產品的基準
  • 值得注意的主要企業
  • 有顛覆性技術的企業
  • Start-Ups企業

第11章 藥物濫用治療市場-企業簡介

  • CureApp Inc.
    • 企業概要
    • 類型組合和概要
    • 主要的焦點
    • 財務概要
  • Allergan PLC
  • Alkermes
  • Noramco
  • Indivior PLC
  • Teva Pharmaceutical Industries Ltd
  • Mallinckrodt plc
  • Tongji Pharmaceutical
  • Wuyao Pharmaceutical
  • API Polpharma

清單非網羅性

第12章 藥物濫用治療市場-DataM

  • 附錄
  • 關於本公司、服務
  • 諮詢方式

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: DMPH3871

Substance Abuse Treatment Market Overview

The substance abuse treatment market size was valued at US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

The use of prescription or OTC drugs or illegal drugs or alcohol in excessive amounts for purposes other than which they are meant to be used is known as substance abuse. Substance abuse may lead to social, physical, emotional, and job-related problems.

Substance Abuse Treatment Market Dynamics

Increasing incidence of drug addiction and rising awareness about substance abuse and its treatment will drive the substance abuse treatment market.

Increasing incidence of drug addiction will drive the substance abuse treatment market

In the previous years about 270 million people had used psychoactive drugs. Around 35 million people are estimated to be affected by drug use disorders (harmful patterns of drug use or drug dependence). According to the World Drug Report, released by the United Nations Office on Drugs and Crime (UNODC) around 35 million people globally are estimated to suffer from drug use disorders and require treatment services. Drug addiction is a disease that affects behavior of perosn,their brain and leads to an uncontrollable use of a illegal or legal drug or medication. Substances such as nicotine, marijuana and alcohol also are considered drugs. Drug addiction can start with the practical use of a recreational drug in social situations and may become more frequent. For others, particularly with opioids, drug addiction begins with exposure to prescribed medications or receiving medications from a friend or relative who has been prescribed the medication. The risk of addiction and how fast you become addicted varies by drug. Some drugs, such as opioid painkillers, have a higher risk and cause addiction more quickly than others.

Drug treatment is intended to help addicted people stop compulsive drug use and seeking. Treatment can occur in various settings,many different forms and may last for different time length. As drug addiction is a chronic disorder typically characterized by occasional relapses, short-term, one-time treatment is usually insufficient. Sometimes treatment is a long-term process involving regular monitoring and multiple interventions.

Rising awareness about substance abuse and its treatment will drive the substance abuse treatment market

Across the nation leaders look for new ways to fight the growing addiction epidemic and raise awareness. As essential therapeutic modalities Prescription drugs classified as controlled dangerous substances are widely accepted in treating various healthcare conditions. For uses other than intended many prescription medications have pleasurable side effects that can appeal to patients to take these drugs. Abuse or misuse of prescription drugs can contribute to addictive behaviors, serious health risks and potentially death. The National Institute on Drug Abuse (NIDA),other state and local agencies across the country maintain a close watch on trends in drug abuse of prescription drugs.

World Drug Day is on June 26. Its goal is to raise awareness about drug addiction and the issues it can create. The U.N. leads this international cause to educate people about drug use and solve this problem globally. Drug addiction treatment helps people with substance use disorders make a safe and lifelong recovery. While treatment can help, World Drug Day seeks to prevent and manage drug use before addiction, and other problems ever begin.

Legal regulation for treatment products will hamper the substance abuse treatment market

Drug legalization advocates believe that making high-quality drugs widely and cheaply available will eliminate the illegal drug market, price,regulate quality and decrease law costs for enforcement, including incarceration and arrest. If drugs from heroin to marijuana become routinely accessible they predict that governments will spend less money on law enforcement, benefit from a new source of tax revenue, and that drug-related crime will fall, more or less as are alcohol and tobacco.

With a big disadvantage legal marijuana competes with illegal marijuana. Legal marijuana is subjected to taxes to add to its price and regulations. Legal marijuana has shown great innovation in products by the suppliers, including the sale of edibles vaping oils and THC concentrates (dabs). Both suppliers have increased the potency of their products, adding to their risks. In 2019, in response to the legalization of marijuana in Massachusetts, scientists and a consortium of clinicians released a Statement of Concern expressing their disagreement with how marijuana policy is being shaped across the state.

COVID-19 Impact Analysis

COVID-19 has affected the healthcare industry. To curb its growth, government-imposed lockdown. People are fearful they will experience occupational effects and negative health from the COVID-19 pandemic. This has seen to affect the substance abuse treatment market as many have stopped manufacturing units.

Substance Abuse Treatment Market Segment Analysis

The tobacco/Nicotine addiction treatment segment will dominate the substance abuse treatment market

Globally, use of tobacco per year causes more than 7 million deaths. All over the globe if the pattern of smoking doesn't change, more than 8 million people a year die from tobacco related diseases in the forecast period.

Infrequent use of nicotine can lead to dependence as it is very addictive.Smoking cessation products such as lozenges, or patches, nicotine gum cause nicotine addiction. Worldwide, habitual use of tobacco and tobacco products continues to be a significant contributor to health problems.

To support tobacco cessation there are effective treatments that include both FDA-approved medications and behavioral therapies. Various forms of nicotine replacement therapy are included in FDA-approved pharmacotherapies as well as varenicline and bupropion. Research states that smokers who receive a combination of cessation medications and behavioral treatment quit at higher rates than the people who receive a minimal intervention. Nicotine Replacement Therapy over the counter a variety of formulations of nicotine NRTs are available including the transdermal patch, gum,spray ,lozenges and are effective equally for cessation. The brain receptors targeted by nicotine are stimulated by NRTs that help relieve nicotine cravings and withdrawal symptoms which leads to relapse. To get through the early stages of cessation many people use NRT, and longer-term treatment may benefit for people with more severe nicotine addiction. Hence, the increasing number of Tobacco/Nicotine addiction and the availability of different treatments will drive the substance abuse treatment market.

The hospital Pharmacy segment will dominate the substance abuse treatment market

A dispensary within a hospital is hospital pharmacy that prepares, compounds, stocks and dispenses inpatient medications. They usually stock a large range of medications, including more investigational and specialized medications, than feasible in the community setting. Community pharmacists are placed well and be invaluable when linking secondary care services with patients. The guidelines are also relevant for allied healthcare professionals and specialist hospital-based pharmacists. They are increasingly likely to encounter drug-using patients with a wide range of physical and mental health problems.

A hospital pharmacy would be the safest place for dispensing substance abuse treatment drugs. Pharmacists are experts in medication and play a significant role in dispensing and monitoring medication to ensure safe and optimal use. Dispensing substance abuse treatment drugs like other medications through pharmacies is the safest option.

Substance Abuse Treatment Market Geographical Analysis

North America region will dominate the substance abuse treatment market

Increasing awareness campaigns and increasing the incidence of substance abuse in this region will drive the treatment market.

In America 1 in 12 adults (18.7 million) had a substance use disorder, and 46.6 million had a mental illness. Though more than 8.5 million were found to have both a SUD and mental illness. Americans more than 16 million are living with a disease caused by smoking. In the United States cigarette smoking is responsible for more than 480,000 deaths per year and secondhand smoke exposure includes more than 41,000 death. This is annually about one in five deaths, or 1,300 deaths every day.

A highly addictive substance nicotine is found in tobacco products. Around 50 million people in America are addicted to some tobacco products, including chewing tobacco,cigars, cigarettes and snuff. Nicotine addiction is the most common addiction in America. According to research from the Commonwealth Fund, in 2020, overdose deaths in the United States exceeded 90,000, compared with 70,630 in 2019. The agency within the U.S. Department of Health and Human Services is Substance Abuse and Mental Health Services Administration (SAMHSA) that leads public health efforts to advance the nation's behavioral health. Its mission is to reduce the impact of substance abuse and mental illness on America's communities.

Substance Abuse Treatment Market Competitive Landscape

Major key players in the substance abuse treatment market are Allergan PLC, Alkermes, Noramco, Indivior PLC, Teva Pharmaceutical Industries Ltd, Pfizer, Inc., Mallinckrodt plc, GlaxoSmithKline plc, Pharmaceuticals Ltd, and BioCorRx, Inc., CureApp Inc.

Substance Abuse Treatment Market Key Companies to Watch

CureApp Inc.

Overview: CureApp® is the leading digital health therapeutic medical device (software) company delivering an innovative solution called "prescription digital therapeutics" to medical treatment fields based on robust scientific evidence. With the recent rapid technological advances, it is becoming clear that interventions with prescription digital therapeutics in daily lives can produce remarkable therapeutic effects in various disease areas.

Product Portfolio: The company comprises Digital Healthcare, Digital Therapeutics, Medical Mobile Application, Mobile Healthcare, Behavioral Science, Self-Management, and Cognitive Behavioral Therapy.

Key Development: CureApp, Inc. has announced that CureApp SC Nicotine Addiction Treatment App and CO Checker, a treatment app targeting nicotine addiction. As of December 1, 2020 it is now covered by Japan's public healthcare insurance system, followed by a period of clinical trials and regulatory approval.

Why Purchase the Report?

  • Visualize the substance abuse treatment market segmentation By Treatment Type and By Distribution channel, highlighting the key commercial assets and players.
  • Identify commercial opportunities in the substance abuse treatment market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of substance abuse treatment market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The substance abuse treatment market report would provide access to an approx. 53 market data table, 41 figures and 200 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Substance Abuse Treatment Market - By Treatment Type

  • Tobacco/Nicotine Addiction Treatment
  • Drug Abuse Treatment
  • Other Treatment Types

Substance Abuse Treatment Market - By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies

Substance Abuse Treatment Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Substance Abuse Treatment Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Substance Abuse Treatment Market - Market Definition and Overview

3. Substance Abuse Treatment Market - Executive Summary

  • 3.1. Market Snippet By Treatment Type
  • 3.2. Market Snippet By Distribution Channel
  • 3.3. Market Snippet By Region

4. Substance Abuse Treatment Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing incidence of drug addiction will drive the substance abuse treatment market
      • 4.1.1.2. Rising awareness about substance abuse and its treatment will drive the substance abuse treatment market
    • 4.1.2. Restraints:
      • 4.1.2.1. Legal regulation for treatment products will hamper the substance abuse treatment market
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Substance Abuse Treatment Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Substance Abuse Treatment Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Substance Abuse Treatment Market - By Treatment Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type Segment
    • 7.1.2. Market Attractiveness Index, By Treatment Type Segment
  • 7.2. Tobacco/Nicotine Addiction Treatment *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Drug Abuse Treatment
  • 7.4. Other Treatment Types

8. Substance Abuse Treatment Market - By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
    • 8.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 8.2. Hospital Pharmacies*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Retail Pharmacies

9. Substance Abuse Treatment Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Substance Abuse Treatment Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking
  • 10.4. Key Companies to Watch
  • 10.5. Company with disruptive technology
  • 10.6. Start Up Companies

11. Substance Abuse Treatment Market - Company Profiles

  • 11.1. CureApp Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Allergan PLC
  • 11.3. Alkermes
  • 11.4. Noramco
  • 11.5. Indivior PLC
  • 11.6. Teva Pharmaceutical Industries Ltd
  • 11.7. Mallinckrodt plc
  • 11.8. Tongji Pharmaceutical
  • 11.9. Wuyao Pharmaceutical
  • 11.10. API Polpharma

LIST NOT EXHAUSTIVE

12. Substance Abuse Treatment Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us